H.R. 1051
Title: To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
Sponser: Budzinski, Nikki [Rep.-D-IL-13] (Introduced 02/06/2025)
Latest Action:
Permanent Link:
pdf:
html:
txt:
Category: